Você está na página 1de 7

Arajo S; Souza DOB; Gonalves MA; Costa AV; Goulart LR; Goulart IMB, et al.

Identificao de portadores sadios e infeco subclnica em contatos domiciliares de


pacientes com hansenase com potencial participao na cadeia de transmisso. Hansen.
Int. 2012;37(2(Suppl. 1)):14.

Arruda MSP; Arruda OS; Astolfi CS; Opromolla DVA.. Estudo das reaes de
fernandez e mitsuda em pacientes hansenianos e seus contatos. Hansen. Int.,10(1/2): 23-
31,1985.

vila JL, Convit J. Studies on cellular immunity in leprosy. I Lysossomal enzymes. Int.
J. Leprosy. 1970; 38(4): 359-364.

Azevedo MCS et al . qPCR detection of Mycobacterium leprae in biopsies and slit skin
smear of different leprosy clinical forms. Braz J Infect Dis. 2017, 21(1): 71-78.

Barth-Jaeggi T, Steinmann P, Mieras L, et al. Leprosy Post-Exposure Prophylaxis


(LPEP) programme: study protocol for evaluating the feasibility and impact on case
detection rates of contact tracing and single dose rifampicin. BMJ Open 2016;
6:e013633.

Baumgart KW, Britton WJ, Mullins RJ, Basten A, Barnetson RS. Subclinical infection
with Mycobacterium leprae - a problem for leprosy control strategies. Trans R Soc Trop
Med Hyg. 1993; 87(4): 412-415.

Brasil. Ministrio da Sade. Secretaria de Polticas de Sade. rea Tcnica de


Dermatologia Sanitria. Guia para utilizao de medicamentos e imunobiolgicos na
rea de hansenase. Braslia, 2010.

Brasil. Ministrio da Sade. Secretaria de Polticas de Sade. Departamento de Ateno


Bsica. Guia para controle da Hansenase. Ministrio da Sade. 1 ed. Braslia. 2002.

Brasil. Ministrio da Sade. Secretaria de Vigilncia em Sade. Diretrizes para


vigilncia, ateno e eliminao da hansenase como problema de sade pblica.
Manual tcnico-operacional, Braslia, 2016.

Brett SJ, Draper P, Payne SN, Rees RJ. Serological activity of a characteristic phenolic
glycolipid from Mycobacterium leprae in sera from patients with leprosy and
tuberculosis. Clin Exp Immunol. 1983; 52:2719.

Bryceson A, Pfaltzgraff RE. Leprosy. London: Churchill Livingstone Inc., 1990.

Buhrer SS, Smits HL, Gussenhoven GC, Van Ingen CW, Klatser PR. A simple dipstick
assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
Am J Trop Med Hyg 1998; 58 (2): 133-136.

Cardona-Castro NM1, Restrepo-Jaramillo S, Gil de la Ossa M, Brennan PJ. Infection by


Mycobacterium leprae of household contacts of lepromatous leprosy patients from a
post-elimination leprosy region of Colombia. Mem Inst Oswaldo Cruz. 2005
100(7):703-7.
Chaptini C, Marshman G. Leprosy: a review on elimination, reducing the disease
burden, and future research. Lepr Rev (2015) 86, 307315

Clark-Curtiss JE, Docherty MA A species-specific repetitive sequence in


Mycobacterium leprae DNA. J Infect Dis 1989; 159: 7-15.

Convit J, Pinardi ME, Rojas FA Some considerations regardings the immunology of


leprosy. Int. J. Leprosy. 1971; 39(2):556-64.

Correa, RGCF et al . Epidemiological, clinical, and operational aspects of leprosy


patients assisted at a referral service in the state of Maranho, Brazil. Rev. Soc. Bras.
Med. Trop., Uberaba , v. 45, n. 1, p. 89-94, Feb. 2012

Cruz RCS, Cunha MGS, Vsquez FG. Prevalncia de anticorpo anti PGL-1 em contatos
domiciliares de pacientes com hansenase. Cad . Sade Coletiva. 2009, 17 (1): 261
271.

Cunha, MHCM et al . Fatores de risco em contatos intradomiciliares de pacientes com


hansenase utilizando variveis clnicas, sociodemogrficas e laboratoriais. Rev Pan-
Amaz Saude, Ananindeua , v. 8, n. 2, p. 21-28, jun. 2017 .

De Wit MY, Faber WR, Krieg SR, Douglas JT, Lucas SB, Montreewasuwat N, Pattyn
SR, Hussain R, Ponnighaus JM, Hartskeerl RA et al. Application of a polymerse chain
raction for the detection of Mycobacterium leprae in skin tissues. J. Clin. Microbiol.
1991; 29: 906-910.

Duthie MS, Gillis TP, Reed SG. Advances and hurdles on the way toward a leprosy
vaccine. Hum Vaccin. 2011;7(11):11721183.

Feenstra, S. Nahar, Q. Pahan, D. Oskam, L. Richardus, J. Social contact patterns and


leoprosy diseae: a case-control study in Bangladesh. Epidemiology and INfextion,
2013; 141 (3): 573-581.

Ferreira, SM. et al. Rifampicin chemoprophylaxis in preventing leprosy in contacts of


patients with leprosy: a comprehensive systematic review protocol. JBI Database of
Systematic Reviews and Implementation Reports, 2015; 13 (2): 84100.

Foss NT, Souza CS, Goulart IMB, Gonalves HS, Virmond M. Hansenase: Episdios
Reacionais. Sociedade Brasileira de Hansenologia & Sociedade Brasileira de
Dermatologia, 2003: 1-19.

Freitas BHBM et al. Tendncia da hansenase em menores de 15 anos em Mato Grosso


(Brasil), 2001-2013. Rev Sade Pblica 2017; 51:28

Goulart IMB, Penha GO, Cunha G. Imunopatologia da hansenase: a complexidade dos


mecanismos da resposta imune do hospedeiro ao Mycobacterium leprae. Rev. Soc.
Bras. Md. Trop. 2002; 35(4):365-375.

Hartskeerl RA, De Wit M Y, Klatser PR. Polymerse chain reaction for the detection of
Mycobacterium leprae. J. Gen. Microbiol. 1989; 135: 2357-2364.
HOEVEN TA, FISCHER EAJ, PAHAN D, RICHARDUS JH. Social distance and
spatial distance are not the same, observations on the use of GIS in leprosy
epidemiology. Epidemiol Infect. 2008 Dec; 136(12): 16241627.

IBGE. Pesquisa Nacional de Sade. Percepo do estado de sade, estilos de vida e


doenas crnicas. Rio de Janeiro: Ministrio do Planejamento, 2014.

Kampirapap K, Singthan N, Klatser PR, Wiriyawipart S DNA amplification for


detection of leprosy and assessment of efficacy of leprosy chemotherapy. Int J Lepr
Other Mycobact Dis. 1998; 66: 16-21.

Kurabachew, M., A. Wondimu, and J. J. Ryon. Reverse transcription-PCR detection of


Mycobacterium leprae in clinical specimens. J. Clin. Microbiol. 1998; 36:13521356.

Lahiri R, Randhawa B, Krahenbuhl JL. Application of a viability-staining method for


Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. J Med
Microbiol 2005; 54:235242.

Lobato, DC; Neves, DO; Xavier, MB. Avaliao das aes da vigilncia de contatos
domiciliares de pacientes com hansenase no Municpio de Igarap-Au, Estado do
Par, Brasil. Rev Pan-Amaz Saude, 2016; 7(1): 45-53.

Marciano, LHSC. Caracterizao clnica epidemiolgica e geogrfica da hansenase em


municpio hiperendmico do Brasil. [Tese]. Botucatu: Universidade Estadual Paulista
Jlio de Mesquita Filho, Faculdade de Medicina de Botucatu; 2015.

Martinez AN, Lahiri R, Pittman TL, Scollard D, Truman R, Moraes MO, Williams D L.
Molecular Determination of Mycobacterium leprae Viability by Use of Real-Time PCR
J Clin Microbiol. 2009; 47(7): 21242130.

Martinez AN, Ribeiro-Alves M, Sarno EN, Moraes MO (2011) Evaluation of qPCR-


based assays for leprosy diagnosis directly in clinical specimens. PLoSNegl Trop Dis 5:
e1354.

Martins, ACC et al . Estudo da mucosa nasal de contatos de hansenase, com


positividade para o antgeno glicolipdio fenlico 1. Braz. J. Otorhinolaryngol. (Impr.),
2010; 76(5): 579-587.

Matos HJ et al. Epidemiologia da hansenase em coorte de contatos intradomiciliares no


Rio de Janeiro (1987-1991). Cad. Sade Pblica [online]. 1999, 15(3): 533-542.

Mira MT, Alcas A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP et al.
Susceptibility to leprosy is associated with PARK2 and PACRG. Nature. 2004;
427(6975):636-40

Modlin RL. Th1-Th2 paradigm: Insights from Leprosy. J. Invest. Dermatol.1994;


102(6): 828-32.
Moet FJ, Oskam L, Faber R, Pahan D, Richardus H. A study on transmission and a trial
of chemoprophylaxis in contacts of leprosy patients: design, methodology and
recruitment findings of COLEP. Lepr Rev. 2004; 75: 376388

Moet FJ, Pahan D, Oskam L, Richardus JH, for the COLEP 1 Study Group.
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of
patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;
336: 761-4.

Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic
relationship, age and leprosy classification are independent risk factors for leprosy in
contacts of patients with leprosy. J Infect Dis. 2006 193: 346-353.

Moura RS et al . Sorologia da hansenase utilizando PGL-I: reviso sistemtica.Rev.


Soc. Bras. Med. Trop. 2008, 41(2): 11-18.

Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, et al.
Analysis of cytokine production by Mycobacterium- reactive T cell. Failure to explain
Mycobacterium leprae- specific nonresponsiveness of peripheral blood T cells from
lepromatous leprosy patients. J. Immunol. 1993; 150(10): 4641-51.

Neto JMP et al. O controle de comunicantes de hansenase no Brasil: uma reviso da


literatura. Hansen Int. 2000; 25 (2): 163-176.

Neto JMP, Carvalho HT, Cunha LES, Cassenote AJF, Lozano AW, Martins APS.
Anlise do controle dos contatos intradomiciliares de pessoas atingidas pela hansenase
no Brasil e no estado de So Paulo de 1991 a 2012. Hansen Int. 2013; 38 (1-2): 68-78.

Neto JMP. Caractersticas epidemiolgicas dos comunicantes de hansenase que


desenvolveram a doena, notificados no C.S./ de Fernandpolis (1993 a 1997).
[Dissertao]. Ribeiro Preto: Escola de Enfermagem de Ribeiro Preto, Universidade
de So Paulo; 1999.

Nicchio MVC, Martin SALC, Pinheiro AV, Pereira DC, Borges A, Antunes DE et al.
Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy
patients and household contacts of an endemic region in Southeast Brazil. Acta Tropica.
2016, 13: 38-45.

Nogueira MES, Vilani-Moreno FR, Silva EA, Arruda MSP. Imunologia. In: Opromolla
DVA. Noes de Hansenologia. 2ed. Bauru: Centro de Estudos Dr Reynaldo
Quagliato. Instituto Lauro de Souza Lima, 2000. p. 27-42.
Opromolla, DVA. Recidiva ou Reao Reversa? Hansenologia Internationalis, 1994; 19
(1):10-16.

Organizao Mundial da Sade, Organizao Pan-Americana da Sade. Manual para o


controle de lepra. 2a ed. Washington, DC, USA: Organizao Mundial da Sade; 1989.
Oskam L, Bakker MI. Report of the workshop on the use of 11 chemoprophylaxis in the
control of leprosy held in Amsterdam, Netherlands on 14th December 2006. Lepr Rev.
2007; 78: 173-85.
Penna MLF, Penna GO, Iglesias PC, Natal S, Rodrigues LC (2016) Anti-PGL-1
Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy
Cases: Systematic Review and Meta-analysis. PLOS Neglected Tropical Diseases
10(5): e0004703. https://doi.org/10.1371/journal.pntd.0004703

Phetsuksiri, B., J. Rudeeaneksin, P. Supapkul, S. Wachapong, K. Mahotarn, and P. J.


Brennan. 2006. A simplified reverse transcriptase PCR for rapid detection of
Mycobacterium leprae in skin specimens. FEMS Immunol. Med. Microbiol. 2006;
3:319328.

Pinho JD, Rivas PM, Mendes MB, Soares RE, Costa GC, Nascimento FR, Paiva MF,
Aquino DM, Figueireido IA, Santos AM, Pereira SR. Presence of Mycobacterium
leprae DNA and PGL-1 antigen in household contacts of leprosy patients from a
hyperendemic area in Brazil. Genet Mol Res. 2015 14(4):14479-87. doi:
10.4238/2015.November.18.10.

Plikaytis BB, Gelber RH, Shinnick TM. Rapid and sensitive detection of
Mycobacterium leprae using a nested-primer gene amplification assay. J Clin Microbiol
1990; 28: 1913-1917.

Plikaytis BB, Gelber RH. Shinnick TM. Rapid and sensitive detection of
Mycobacterium leprae using a nested-primer gene amplification assay. J. Clin.
Microbiol. 1990; 28: 1913-1917.

Rea TH, Quismorio FP, Harding B, Nies KM, Di Saia PJ, Levan NE, et al.
Immunologic responses in pacients with lepromatous leprosy. Arch. Dermatol. 1976;
112(6):791-800.

Richardus JH, Meima A, van Marrewijk CJ, Croft RP, Smith TC 2005. Close contacts
with leprosy in newly diagnosed leprosy patients in a high and low endemic area:
comparison between Bangladesh and Thailand. Int J Lepr Other Mycobact Dis 73: 249-
257.

Ridley DS, Jopling WH. Classification of Leprosy According to Immunity. A five-


group system. Int. J. Leprosy. 1966; 34(3): 255-73.

Rocha, CA. Caracterizao dos comunicantes em um ambulatrio de referncia para


hansenase na cidade de Salvador-Bahia. [Dissertao]. Salvador: Universidade Federal
da Bahia, Faculdade de Medicina da Bahia. Programa de Ps-Graduao em Cincias da
Sade; 2016.

Rudeeaneksin J, Srisungngam S , Sawanpanyalert P , Sittiwakin T , Likanonsakul S,


Pasadorn S et. al., LightCycler real-time PCR for rapid detection and quantitation of
Mycobacterium leprae in skin specimens. FEMS Immunol. Med. Microbiol. 2008; 54
(2): 263-70.

Sales AM, Ponce de Leon A, Dppre NC, Hacker MA, Nery JA, Sarno EN et
al. Leprosy among Patient Contacts: A Multilevel Study of Risk Factors. PLoS Negl
Trop Dis. 2011;5(3):e1013.
Santos AR, De Miranda AB, Sarno EN et al. Use of PCR-mediated amplification of
Mycobacterium leprae DNA in different types of clinical samples for the diagnosis of
leprosy. J Med Microbiol 1993; 39: 298-304.

Santos AR, Goes Filho JT, Nery JA, Duppre NC, Gallo ME, Suffys PN, Degrave WM.
Evaluation of PCR mediated DNA amplification in non-invasive biological specimens
for subclinical detection of Mycobacterium leprae. FEMS Immunol. Med. Microbiol.
1995; 11: 113-120.

Santos AR, Nery JA, Duppre NC, Gallo ME, Goes Filho JT, Suffys PN, Degrave WM.
Use of the polymerase chain reaction in the diagnosis of leprosy. J. Med. Microbiol.
1997; 46: 170-172.

Santos D, Duppre NC, Sales AM, Nery JAC, Sarno EM, Hacker MA. Anlise dos
fatores de risco para o adoecimento em coorte de contatos de pacientes de hansenase,
acompanhados no ambulatrio Souza Arajo/fiocruz, 1987- 2010. In: 12 Congresso
Brasileiro de Hansenologia / Congresso Regional da ILA Amricas. 2011 Nov 23-26;
Maceio: Hansenologia Internationalis. 2011, 36(1): 116.

Santos, DAS et al. Educando para o diagnstico precoce da hansenase no municpio de


Rondonpolis - Mato Grosso. Extensoo: Revista Eletrnica de Extenso de
Florianpolis. 2016; 13 (23): 45-61.

Scollard DM, Gillis TP, Williams DL. Polymerse chain reaction assay for the detection
and identification of Mycobacterium leprae in patients in the United States. Am. J. Clin.
Pathol. 1998; 109: 642-646.

Shepard, C.C. The experimental disease that follows the injection of human leprosy
bacilli into foot pads of mice. J. exp med.1960; 112: 445-54.

Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in


endemic countries: a systematic review and metaanalysis. J Infect. 2000; 41: 137-42.

Stefani MM, Martelli CM, Gillis TP, Krahenbuhl JL. In situ type 1 cytokine gene
expression and mechanisms associated with early leprosy progression. J. Infect. Dis.
2003; 188(7): 1024-1031.

Stefani MM. Desafios na era ps genmica para o desenvolvimento de testes


laboratoriais para o diagnstico da hansenase. Rev. Soc. Bras. Med. Trop. 2008; 41(2):
89-94.

Suttels V, Lenaerts T. Epidemiology and spatial exploratory analysis of leprosy in the


district of Toliara, Madagascar. Lepr Rev. 2016, 87: 305 313

Ura S, Dirio SM, Carreira BG, Trino LM, Lauris JR, Barravieira B. Estudo teraputico
comparando a associao de rifampicina, ofloxacina e minociclina com associao
rifampicina, clofazimina e dapsona em pacientes com hansenase multibacilar. Hansen
Int. 2007; 32(1): 57-65.
Virmond, M., Grzybowski, A. Leprosy - an intriguing disease. Clinics in Dermatology.
2015, 33: 12.

WHO. Global Leprosy Strategy 2016-2020 Accelerating towards a leprosy-free world.


WHO-SEARO, 2016. Disponvel em:
http://www.who.int/lep/resources/9789290225096/en/

Williams DL, Gillis TP, Booth RJ, Llooker D, Watson JD. The use of a specific DNA
probe and polymerase chain reaction for the detecion of Mycobacterium leprae. J.
Infect. Dis. 1990; 162: 193-200.

Woods SA, Cole ST. A rapid method for detection of potentially viable Mycobacterium
leprae in human biopsies: a novel application of PCR. FEMS Microbiol Lett. 1989; 53:
305-309.

Woods SA, Cole ST. A family of dispersed repeats in Mycobacterium leprae. Mol.
Microbiol. 1990; 4: 1745-1751.

World Health Organization 1987. Laboratory Techniques for leprosy. World Health
Organization, Geneva.

World Health Organization. Global leprosy update, 2013; reducing disease burden.
Wkly Epidemiol Rec, 2017; 92(35): 501-520.

World Health Organization. Global leprosy update, 2015 :time for action, accountability
and inclusion. Wkly Epidemiol Rec. 2016; 91(35):405-20.

Yoon KH, Cho SN, Lee MK, Abalos RM, Cellona RV, Fajardo TT, Guido LS, Dela
Cruz EC, Walsh GP, Kim JD. Evaluation of polymerase chain reaction amplification of
Mycobacterium leprae-specific repetitive sequence in biopsy specimens from leprosy
patients. J Clin Microbiol1993, 31 (4): 895-899.